Low vaccination rates in poorer countries have little to do with so-called "vaccine hesitancy" according to a study that examined access to COVID-19 tools across 14 low-income countries.
Oct 6, 2022
0
10
LSU researchers have built a cancer drug discovery engine powered by AI that soon could match any type of cancer, based on a small cell sample from a patient, with the drug most likely to cure that cancer.
Sep 28, 2022
0
12
A lipid found in the membranes of neurons may play a fundamental role in the development and progression of Alzheimer's disease, according to a study by Penn State College of Medicine researchers. Their findings, published ...
Aug 19, 2022
0
69
Maternal or paternal exposure to pesticides does not appear to be associated with increased risks for childhood cancer, according to a study published online July 6 in Environmental Research.
Aug 9, 2022
0
14
A new machine learning method to model gene expression levels might improve the identification of genes that cause human diseases, according to a new study by Penn State College of Medicine researchers. Through information ...
Jun 29, 2022
0
36
La Trobe University researchers have found that multiple barriers continue to prevent some people from accessing life-saving new hepatitis C treatment, including experiences of stigma within the health care system.
May 31, 2022
0
2
Throughout the pandemic the University of Huddersfield's Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they're an important part of the healthcare strategy as well ...
May 25, 2022
0
3
One million dead from COVID-19: two years ago it would have been unimaginable, but now the United States is on the verge of surpassing this terrible milestone.
May 12, 2022
0
3
When brain scientist Birgitte Kornum from the Department of Neuroscience recently arrived in Rome for one of the largest sleep conferences in the world, she was completely taken aback. There were pharmaceutical companies ...
Apr 29, 2022
0
192
(HealthDay)—Daily oral perampanel is generally well tolerated, with favorable retention rates among patients with epilepsy aged 1 to younger than 18 years, according to a study recently published in the Journal of Child ...
Mar 17, 2022
0
7
